Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & EnergyDetailed TOC of Global Point-of-Care Testing (POCT) Market – Trends and Forecast To 2024
1. INTRODUCTION1.1. OVERVIEW OF THE GLOBAL POINT-OF-CARE TESTING MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL POINT-OF-CARE TESTING MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. PRODUCT PIPELINE ANALYSIS
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL POINT-OF-CARE TESTING MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL POINT-OF-CARE TESTING MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. HIGH PREVALENCE OF INFECTIOUS DISEASES IN DEVELOPING COUNTRIES
4.3.1.2. INCREASING INCIDENCE OF LIFESTYLE DISEASES
4.3.1.3. RISING USAGE OF HOME-BASED POC DEVICES
4.3.1.4. GROWING NUMBER OF REGULATORY APPROVALS FOR NOVEL IMMUNOASSAY TECHNIQUES
4.3.1.5. SHORTAGE OF SKILLED LABORATORY TECHNICIANS INCREASING PREFERENCE OF POC TESTING
4.3.1.6. RISING INCIDENCE OF UNPLANNED PREGANANCIES
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. POINT-OF-CARE TESTING MARKET, BY TYPE
5.1. OVERVIEW
5.2. CARDIOMETABOLIC MONITORING KITS, BY PRODUCT TYPE
5.2.1. CARDIAC MARKERS
5.2.2. BLOOD GAS ELECTROLYTE TESTING KITS
5.2.3. HBA1C TESTING KITS
5.2.4. LIPID TESTING KITS
5.3. INFECTIOUS DISEASE TESTING KITS, BY PRODUCT TYPE
5.3.1. INFLUENZA TESTING KITS
5.3.2. HIV TESTING KITS
5.3.3. HEPATITIS C TESTING KITS
5.3.4. STD TESTING KITS
5.3.5. TROPICAL DISEASE TESTING KITS
5.3.6. HEALTHCARE ASSOCIATED INFECTIONS TESTING KITS
5.3.7. RESPIRATORY INFECTIONS TESTING KITS
5.3.8. OTHERS
5.4. CHOLESTROL TESTING KITS, BY PRODUCT TYPE
5.4.1. PROTHROMBIN TIME TESTING KITS
5.4.2. ACTIVATED CLOTTING TIME TESTING KITS
5.5. BLOOD GLUCOSE TESTING KITS
5.6. PREGNANCY AND FERTILITY TESTING KITS
5.7. TUMOR CANCER MARKERS
5.8. URINALYSIS TESTING KITS
5.9. HEMATOLOGY TESTING KITS
5.10. DRUGS OF ABUSE TESTING KITS
5.11. FECAL OCCULT TESTING KITS
5.12. RAPID COAGULATION TESTING KITS
5.13. OTHERS
6. POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE
6.1. OVERVIEW
6.2. PRESCRIPTION BASED TESTING KITS
6.3. OVER THE COUNTER (OTC) BASED TESTING KITS
7. POINT-OF-CARE TESTING MARKET, BY END-USER
7.1. OVERVIEW
7.2. HOSPITALS
7.3. CLINICS
7.4. AMBULATORY CARE
7.5. HOME HEALTHCARE
7.6. RESEARCH LABORATORY
8. POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DIRECT TENDERS
8.3. RETAIL
9. POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE POINT OF CARE TESTING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.1.1. NORTH AMERICA
9.1.1.1. U.S.
9.1.1.2. CANADA
9.1.1.3. MEXICO
9.1.2. EUROPE
9.1.2.1. GERMANY
9.1.2.2. FRANCE
9.1.2.3. U.K.
9.1.2.4. ITALY
9.1.2.5. SPAIN
9.1.2.6. RUSSIA
9.1.2.7. TURKEY
9.1.2.8. BELGIUM
9.1.2.9. NETHERLANDS
9.1.2.10. SWITZERLAND
9.1.2.11. REST OF EUROPE
9.1.3. ASIA-PACIFIC (APAC)
9.1.3.1. JAPAN
9.1.3.2. CHINA
9.1.3.3. SOUTH KOREA
9.1.3.4. INDIA
9.1.3.5. AUSTRALIA
9.1.3.6. SINGAPORE
9.1.3.7. THAILAND
9.1.3.8. MALAYSIA
9.1.3.9. INDONESIA
9.1.3.10. PHILIPPINES
9.1.3.11. REST OF APAC
9.1.4. LATIN AMERICA
9.1.4.1. BRAZIL
9.1.4.2. REST OF LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.1.5.1. SOUTH AFRICA
9.1.5.2. REST OF MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. POINT-OF-CARE TESTING MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL POINT OF CARE TESTING MARKET: COMPANY SHARE ANALYSIS
10.2. U.S. POINT OF CARE TESTING MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE POINT OF CARE TESTING MARKET: COMPANY SHARE ANALYSIS
10.4. APAC POINT OF CARE TESTING MARKET: COMPANY SHARE ANALYSIS
10.5. SOUTH AMERICA POINT OF CARE TESTING MARKET: COMPANY SHARE ANALYSIS
10.6. MEA POINT OF CARE TESTING MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.9. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11. POINT-OF-CARE TESTING MARKET: COMPANY PROFILES
11.1. ABBOTT LABORATORIES, INC.
11.1.1 COMPANY OVERVIEW
11.1.2 SWOT ANALYSIS
11.1.3 REVENUE ANALYSIS
11.1.4 PRODUCT PORTFOLIO
11.1.5 RECENT DEVELOPEMENTS
11.1.6 DATA BRIDGE ANALYSIS
11.2. ROCHE DIAGNOSTICS LIMITED
11.2.1 COMPANY OVERVIEW
11.2.2 SWOT ANALYSIS
11.2.3 REVENUE ANALYSIS
11.2.4 PRODUCT PORTFOLIO
11.2.5 RECENT DEVELOPEMENTS
11.2.6 DATA BRIDGE ANALYSIS
11.3. SIEMENS AG
11.3.1 COMPANY OVERVIEW
11.3.2 SWOT ANALYSIS
11.3.3 REVENUE ANALYSIS
11.3.4 PRODUCT PORTFOLIO
11.3.5 RECENT DEVELOPEMENTS
11.3.6 DATA BRIDGE ANALYSIS
11.4. BECKMAN COULTER, INC.
11.4.1 COMPANY OVERVIEW
11.4.2 SWOT ANALYSIS
11.4.3 REVENUE ANALYSIS
11.4.4 PRODUCT PORTFOLIO
11.4.5 RECENT DEVELOPEMENTS
11.4.6 DATA BRIDGE ANALYSIS
11.5. BECTON, DICKINSON AND COMPANY
11.5.1 COMPANY OVERVIEW
11.5.2 SWOT ANALYSIS
11.5.3 REVENUE ANALYSIS
11.5.4 PRODUCT PORTFOLIO
11.5.5 RECENT DEVELOPEMENTS
11.5.6 DATA BRIDGE ANALYSIS
11.6. JOHNSON & JOHNSON
11.6.1 COMPANY OVERVIEW
11.6.2 SWOT ANALYSIS
11.6.3 REVENUE ANALYSIS
11.6.4 PRODUCT PORTFOLIO
11.6.5 RECENT DEVELOPEMENTS
11.6.6 DATA BRIDGE ANALYSIS
11.7. ALERE INC.
11.7.1 COMPANY OVERVIEW
11.7.2 SWOT ANALYSIS
11.7.3 REVENUE ANALYSIS
11.7.4 PRODUCT PORTFOLIO
11.7.5 RECENT DEVELOPEMENTS
11.7.6 DATA BRIDGE ANALYSIS
11.8. INSTRUMENTATION LABORATORY
11.8.1 COMPANY OVERVIEW
11.8.2 SWOT ANALYSIS
11.8.3 REVENUE ANALYSIS
11.8.4 PRODUCT PORTFOLIO
11.8.5 RECENT DEVELOPEMENTS
11.8.6 DATA BRIDGE ANALYSIS
11.9. PTS DIAGNOSTICS
11.9.1 COMPANY OVERVIEW
11.9.2 SWOT ANALYSIS
11.9.3 REVENUE ANALYSIS
11.9.4 PRODUCT PORTFOLIO
11.9.5 RECENT DEVELOPEMENTS
11.9.6 DATA BRIDGE ANALYSIS
11.10. ABAXIS, INC.
11.10.1 COMPANY OVERVIEW
11.10.2 SWOT ANALYSIS
11.10.3 REVENUE ANALYSIS
11.10.4 PRODUCT PORTFOLIO
11.10.5 RECENT DEVELOPEMENTS
11.10.6 DATA BRIDGE ANALYSIS
11.11. MEDTRONIC
11.11.1 COMPANY OVERVIEW
11.11.2 SWOT ANALYSIS
11.11.3 REVENUE ANALYSIS
11.11.4 PRODUCT PORTFOLIO
11.11.5 RECENT DEVELOPEMENTS
11.11.6 DATA BRIDGE ANALYSIS
11.12. ACCRIVA DIAGNOSTICS
11.12.1 COMPANY OVERVIEW
11.12.2 SWOT ANALYSIS
11.12.3 REVENUE ANALYSIS
11.12.4 PRODUCT PORTFOLIO
11.12.5 RECENT DEVELOPEMENTS
11.12.6 DATA BRIDGE ANALYSIS
11.13. OPTI MEDICAL
11.13.1 COMPANY OVERVIEW
11.13.2 SWOT ANALYSIS
11.13.3 REVENUE ANALYSIS
11.13.4 PRODUCT PORTFOLIO
11.13.5 RECENT DEVELOPEMENTS
11.13.5 DATA BRIDGE ANALYSIS
11.14. SIENCO, INC.
11.14.1 COMPANY OVERVIEW
11.14.2 SWOT ANALYSIS
11.14.3 REVENUE ANALYSIS
11.14.4 PRODUCT PORTFOLIO
11.14.5 RECENT DEVELOPEMENTS
11.14.6 DATA BRIDGE ANALYSIS
11.15. ALPHA SCIENTIFIC
11.15.1 COMPANY OVERVIEW
11.15.2 SWOT ANALYSIS
11.15.3 REVENUE ANALYSIS
11.15.4 PRODUCT PORTFOLIO
11.15.5 RECENT DEVELOPEMENTS
11.15.6 DATA BRIDGE ANALYSIS
11.16. ACCUBIOTECH CO. LTD.
11.16.1 COMPANY OVERVIEW
11.16.2 SWOT ANALYSIS
11.16.3 REVENUE ANALYSIS
11.16.4 PRODUCT PORTFOLIO
11.16.5 RECENT DEVELOPEMENTS
11.16.5 DATA BRIDGE ANALYSIS
11.17. ACON LABORATORIES, INC.
11.17.1 COMPANY OVERVIEW
11.17.2 SWOT ANALYSIS
11.17.3 REVENUE ANALYSIS
11.17.4 PRODUCT PORTFOLIO
11.17.5 RECENT DEVELOPEMENTS
11.17.6 DATA BRIDGE ANALYSIS
11.18. ACRONGENOMICS
11.18.1 COMPANY OVERVIEW
11.18.2 SWOT ANALYSIS
11.18.3 REVENUE ANALYSIS
11.18.4 PRODUCT PORTFOLIO
11.18.5 RECENT DEVELOPEMENTS
11.18.6 DATA BRIDGE ANALYSIS
11.19. BIOMÉRIEUX, BIOMERICA, INC.
11.19.1 COMPANY OVERVIEW
11.19.2 SWOT ANALYSIS
11.19.3 REVENUE ANALYSIS
11.19.4 PRODUCT PORTFOLIO
11.19.5 RECENT DEVELOPEMENTS
11.19.6 DATA BRIDGE ANALYSIS
11.20. ATLAS GENETICS LTD.
11.20.1 COMPANY OVERVIEW
11.20.2 SWOT ANALYSIS
11.20.3 REVENUE ANALYSIS
11.20.4 PRODUCT PORTFOLIO
11.20.5 RECENT DEVELOPEMENTS
11.20.6 DATA BRIDGE ANALYSIS
11.21. ALFA SCIENTIFIC DESIGNS, INC.
11.21.1 COMPANY OVERVIEW
11.21.2 SWOT ANALYSIS
11.21.3 REVENUE ANALYSIS
11.21.4 PRODUCT PORTFOLIO
11.21.5 RECENT DEVELOPEMENTS
11.21.6 DATA BRIDGE ANALYSIS
11.22. BIO-RAD LABORATORIES, INC.
11.22.1 COMPANY OVERVIEW
11.22.2 SWOT ANALYSIS
11.22.3 REVENUE ANALYSIS
11.22.4 PRODUCT PORTFOLIO
11.22.5 RECENT DEVELOPEMENTS
11.22.6 DATA BRIDGE ANALYSIS
11.23. MEDICA CORPORATION
11.23.1 COMPANY OVERVIEW
11.23.2 SWOT ANALYSIS
11.23.3 REVENUE ANALYSIS
11.23.4 PRODUCT PORTFOLIO
11.23.5 RECENT DEVELOPEMENTS
11.23.6 DATA BRIDGE ANALYSIS
11.24. NOVA BIOMEDICAL
11.24.1 COMPANY OVERVIEW
11.24.2 SWOT ANALYSIS
11.24.3 REVENUE ANALYSIS
11.24.4 PRODUCT PORTFOLIO
11.24.5 RECENT DEVELOPEMENTS
11.24.6 DATA BRIDGE ANALYSIS
12. APPENDIX
12.1. SOURCES AND BIBLIOGRAPHY
12.2. RELATED REPORTS
12.3. A GLIMSE OF DATA BRIDGE MARKET RESEARCH FACTBOOK
13. ABOUT DATA BRIDGE MARKET RESEARCH
REQUEST TABLES & FIGURES MENTIONED IN THIS REPORT
